Assessing the Associations of Growth Differentiation Factor 15 with Rheumatic Diseases Using Genetic Data

• DOI: 10.2147/clep.s305024
• Publication Date: 2021-03-22T17:45:12Z
• Authors: Ding Ye; Bin Liu; Zhixing He; Lin Huang; Yu Qian; Keding Shao; Chengping Wen; Yingying Mao
• Keywords: rheumatoid arthritis; 0301 basic medicine; Infectious and parasitic diseases; RC109-216; growth differentiation factor 15; 3. Good health; 03 medical and health sciences; systemic lupus erythematosus; inflammatory bowel disease; single nucleotide polymorphism; mendelian randomization; Clinical Epidemiology; Original Research

To investigate the potential causal associations of circulating levels of growth differentiation factor 15 (GDF-15) with the risk of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) using a Mendelian randomization (MR) design.A genome-wide association study (GWAS) of GDF-15 among 5,440 individuals of European ancestry was used to identify genetic instruments. Summary statistics of SLE, RA and IBD were obtained from publicly available GWASs. We conducted an MR study using the inverse-variance weighted (IVW) method, supplemented with simple-median and weighted-median methods. Cochran Q test and MR-Egger regression were used to detect potential heterogeneity and directional pleiotropy. Odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated.We found that genetically predicted high circulating GDF-15 levels were associated with a decreased risk of SLE (OR 0.80, 95% CI 0.68-0.92 by IVW), with similar results in sensitivity analyses. In replication analysis using summary data from another SLE GWAS, the results were consistent (OR 0.82, 95% CI 0.71-0.93 by IVW). Moreover, no evidence of heterogeneity or pleiotropy was detected. However, genetically determined circulating levels of GDF-15 were not associated with risk of RA or IBD in the primary analysis and subsequent sensitivity analyses.Our study suggested an inverse association between circulating GDF-15 levels and risk of SLE, and further studies are warranted to elucidate the underlying biological mechanisms. There was limited evidence supporting a causal association of circulating GDF-15 levels with risk of RA and IBD.